Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02453594 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087) |
| First Submitted : | May 21, 2015 |
| First Submitted that Met QC Criteria : | May 21, 2015 |
| First Posted : | May 25, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 12, 2024 |
| Last Update Posted : | January 16, 2024 |